SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-13-001332
Filing Date
2013-04-05
Accepted
2013-04-05 16:15:52
Documents
8
Period of Report
2013-05-22
Effectiveness Date
2013-04-05

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT geron_def14a.htm DEF 14A 811232
2 GRAPHIC geron_def14a1x1x1.jpg GRAPHIC 4547
3 GRAPHIC geron_def14a1x1x2.jpg GRAPHIC 8858
4 GRAPHIC geron_def14a1x2x1.jpg GRAPHIC 4547
5 GRAPHIC geron_def14a1x2x2.jpg GRAPHIC 8046
6 GRAPHIC geron_def14a6x10x1.jpg GRAPHIC 8787
7 GRAPHIC geron_def14a6x11x1.jpg GRAPHIC 13503
8 GRAPHIC proxycardx1x1.jpg GRAPHIC 5529
  Complete submission text file 0001206774-13-001332.txt   887618
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20859 | Film No.: 13746096
SIC: 2834 Pharmaceutical Preparations